Securing COVID-19 vaccine supply just as hard as the science

The Australian government can’t rely on the two local COVID-19 vaccine hopefuls to deliver a viable treatment, with local industry experts urging it to cast a wider net to secure sufficient supplies of any future remedy.

There are more than 100 vaccine candidates working their way through trials worldwide, with the University of Queensland, working with blood products maker CSL, and South Australian startup Vaxine already moving to human trials.

However, some industry insiders have privately expressed concern to The Sydney Morning Herald and The Age that the government is too focused on the University of Queensland’s project and risks missing out on global opportunities. Full article here

Leave a Reply

Your email address will not be published. Required fields are marked *